Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 31, 2008European Respiratory JournalOpen Access

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?: Table 1—

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiovanni Battista MiglioriUniversity of GenevaCLChristoph LangeUniversität HamburgEGEnrico GirardiIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Migliori et al. (2008) studied this question.

synapsesocial.com/papers/6aa17cd3408cd2a7443c7c50https://doi.org/10.1183/09031936.00159807
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical and operational value of the extensively drug-resistant tuberculosis definition2007 · 196 citations
  2. 2125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?2007 · 188 citations
  3. 3Origin of the term XDR-TB2007 · 27 citations
  4. 4Extensively Drug-resistant Tuberculosis, Italy and Germany2007 · 112 citations
  5. 5Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis2004 · 337 citations